1-1 of 1
Candida Fratazzi, MD
Close
Sort by
Journal Articles

Phase I/II, Nine Month Study Results of Enzyme Replacement Therapy with Gene Activated Human Glucocerebrosidase (GA-GCB) in Patients with Type I Gaucher Disease.

Ari Zimran, MD, Candida Fratazzi, MD, Robert Mensah, PhD, Deborah Elstein, PhD
Journal: Blood
Blood (2005) 106 (11): 3882.
https://doi.org/10.1182/blood.V106.11.3882.3882
Published: 2005